{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:34:58Z","timestamp":1787070898458,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.4103\/aian.aian_430_23","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T13:00:54Z","timestamp":1694437254000},"page":"366-367","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["ACHR-Positive Generalized Myasthenia Gravis: The Old is Gold and the New Is for us to Explore"],"prefix":"10.4103","volume":"26","author":[{"given":"Fu Liong","family":"Hiew","sequence":"first","affiliation":[{"name":"Neurology Division, Department of Medical, Sunway Medical Centre, Bandar Sunway, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"key":"R1-20240828","first-page":"1","article-title":"Conventional and emerging treatments and controversies in myasthenia gravis","author":"Evoli","year":"2023","journal-title":"Expert Rev Neurother"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4103\/aian.aian_186_23","article-title":"The clinical outcome in AChR positive generalised myasthenia gravis:A retrospective observational study","volume":"26","author":"Ojha","year":"2023","journal-title":"Ann Indian Acad Neurol"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamaneurol.2022.2887","article-title":"Efficacy and safety of rituximab for new-onset generalized myasthenia gravis:The RINOMAX randomized clinical trial","volume":"79","author":"Piehl","year":"2022","journal-title":"JAMA Neurol"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","article-title":"International consensus guidance for management of myasthenia gravis:2020 update","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1474-4422(21)00463-4","article-title":"Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders","volume":"21","author":"Verschuuren","year":"2022","journal-title":"Lancet Neurol"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00000658-193910000-00005","article-title":"Myasthenia gravis and tumors of the thymic region:Report of a case in which the tumor was removed","volume":"110","author":"Blalock","year":"1939","journal-title":"Ann Surg"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.thorsurg.2018.12.003","article-title":"A neurologist's perspective on thymectomy for myasthenia gravis:Current perspective and future trials","volume":"29","author":"Mi","year":"2019","journal-title":"Thorac Surg Clin"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s13311-022-01196-w","article-title":"Evolution of anti-B cell therapeutics in autoimmune neurological diseases","volume":"19","author":"Stathopoulos","year":"2022","journal-title":"Neurotherapeutics"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"686466","DOI":"10.3389\/fimmu.2021.686466","article-title":"Short- and long-lived autoantibody-secreting cells in autoimmune neurological disorders","volume":"12","author":"Zografou","year":"2021","journal-title":"Front Immunol"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3389\/fimmu.2020.00613","article-title":"Long-lasting rituximab-induced reduction of specific-but not total-IgG4 in MuSK-positive myasthenia gravis","volume":"11","author":"Marino","year":"2020","journal-title":"Front Immunol"},{"key":"R11-20240828","first-page":"e376","article-title":"Phase 2 trial of rituximab in acetylcholine receptor antibody-positive generalized myasthenia gravis:The BeatMG study","volume":"98","author":"Nowak","year":"2021","journal-title":"Neurology"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/jnnp-2019-322606","article-title":"Rituximab in AChR subtype of myasthenia gravis:Systematic review","volume":"91","author":"Di Stefano","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jocn.2020.11.043","article-title":"Efficacy and safety of different dosages of rituximab for refractory generalized AChR myasthenia gravis:A meta-analysis","volume":"85","author":"Li","year":"2021","journal-title":"J Clin Neurosci"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/jamaneurol.2020.0851","article-title":"Comparison between rituximab treatment for new-onset generalized myasthenia gravis and refractory generalized myasthenia gravis","volume":"77","author":"Brauner","year":"2020","journal-title":"JAMA Neurol"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/WNL.55.1.7","article-title":"Practice parameter:Thymectomy for autoimmune myasthenia gravis (an evidence-based review):Report of the quality standards subcommittee of the American academy of neurology","volume":"55","author":"Gronseth","year":"2000","journal-title":"Neurology"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_430_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:38:31Z","timestamp":1787067511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_430_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/aian.aian_430_23","relation":{},"ISSN":["0972-2327","1998-3549"],"issn-type":[{"value":"0972-2327","type":"print"},{"value":"1998-3549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2023-05-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}